Aim To explore factors related to chronic obstructive pulmonary disease (COPD) admissions and NIV use that may explain ... NIV appears to be often used as a ceiling of treatment including patient ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations ... early diagnosis and treatment for myasthenia gravis have great ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease treatment failure rates, decrease the risk of relapse, and may improve symptoms and decrease ...

You may have COPD if you notice persistent, prolonged changes to your breathing. Symptoms can include: These symptoms usually worsen over time without treatment. You can also develop conditions ...